Computerized dashboard can ID potentially inappropriate meds

Computerized dashboard can ID potentially inappropriate meds

(HealthDay)—A computerized potentially inappropriate medications (PIMs) dashboard can allow identification of older inpatients on high-risk medication regimens, according to research published online Nov. 3 in the Journal of the American Geriatrics Society.

Josh F. Peterson, M.D., M.P.H., from Vanderbilt University in Nashville, Tenn., and colleagues developed an electronic tool to identify hospitalized adults, aged 65 years and older, who were administered one medication from a list of 240 PIMs. Individuals with at least one administered PIM were flagged using a computerized PIMS dashboard. The flagged records were reviewed by a clinical pharmacist who delivered an immediate point-of-care intervention for the treating physician in a pilot implementation.

The researchers found that 22 percent of the 797 individuals admitted over a three-week period were flagged by the PIMS dashboard, and 485 participant-medication pairs were identified for review by the clinical pharmacist. Additional manual review of the was necessary for 71 participant records with 139 participant-medication pairs. An intervention was warranted for 22 participants receiving 40 inappropriate medication orders, and the intervention was delivered by telephone or text message. Clinicians enacted 78 percent of the pharmacist recommendations.

"An electronic PIM dashboard provided an efficient mechanism for clinical pharmacists to rapidly screen the of hospitalized elderly adults and deliver a timely point-of-care intervention when indicated," the authors write.

Explore further

Telephone intervention doesn't aid diabetes meds adherence

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2014 HealthDay. All rights reserved.

Citation: Computerized dashboard can ID potentially inappropriate meds (2014, November 12) retrieved 18 October 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more